THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE
Сохранить в:
BORG, L., ET AL., THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE. JOURNAL OF ADDICTIVE DISEASES, Vol. 21, no. 3 (2002), p. 13-22.
Ref.
113950
Хранение:
SIIS R.926 Archivo
Palabras clave:
Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Heroína, Metadona, Opiáceos, Programas de mantenimiento, Tratamiento médico
Drogas ilegales, Drogodependencias, Efectos, Evaluación de servicios, Fármacos, Heroína, Metadona, Opiáceos, Programas de mantenimiento, Tratamiento médico
Схожие документы: THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE
- AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE
- LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE
- LEVO ALPHA ACETYLMETHADOL (LAAM) VERSUS METHADONE MAINTENANCE: 1 YEAR TREATMENT RETENTION, OUTCOMES AND STATUS
- METHADONE VS. L-ALPHA-ACETYLMETHADOL (LAAM) IN THE TREATMENT OF OPIATE ADDICTION
- A RANDOMIZED TRIAL COMPARING LEVO-ALPHA ACETYLMETHADOL WITH METHADONE MAINTENANCE FOR PATIENTS IN PRIMARY CARE SETTING IN AUSTRALIA
- LEVO-ALPHA-ACETYLMETHADOL (LAAM): CLINICAL, RESEARCH, AND POLICY ISSUES OF A NEW PHARMACOTHERAPY FOR OPIOID ADDICTION